Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: aTyr Pharma Inc., 3 years.
aTyr Pharma Inc.
Director
Travere Therapeutics Inc.
Director
Fate Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 30, 2024 | aTyr Pharma Inc. | Open-market purchase | +50,000 | $1.75 | $87,500 |
| May 8, 2024 | Travere Therapeutics Inc. | Grant or award | +6,500 | — | — |
| May 17, 2023 | aTyr Pharma Inc. | Gift | −6,000 | — | — |
| May 17, 2023 | Travere Therapeutics Inc. | Grant or award | +4,500 | — | — |
| May 17, 2023 | aTyr Pharma Inc. | Gift | +6,000 | — | — |
| Apr 26, 2023 | aTyr Pharma Inc. | Option exercise | +6,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.